Skip to main content
Caplight Logo









eversyn GmbH

eversyn GmbH

Private
MagdeburgHealthcare & Life Scienceshttps://www.eversyn.de/

Last Round

Grant

Jun 1, 2026

Total Funding Raised

$2.81M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

eversyn GmbH is a biotechnology company that develops cell-free enzymatic platforms for the cost-effective production of complex glycans, including human milk oligosaccharides and nucleotide sugars for nutrition and pharmaceutical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

cell-free biosynthesishuman milk oligosaccharidesHMOnucleotide sugarsglycoengineeringbiocatalysisglycosyltransferasesglycosidasescustom synthesisbiotech reagentssynthetic biologyenzyme productionprotein glycosylationbiotech manufacturingsynbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

eversyn GmbH Comparables

Compare eversyn GmbH with similar companies based on industry and business-model similarity.

eversyn GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inbiose
78%
CD BioGlyco
78%
Zymtronix
78%

eversyn GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 1, 2026
SeedMar 20, 2025
GrantOct 20, 2022

Key People

Founding team and executive leadership

Rachel Thu Nguyen

Co-Founder & Chief Business Officer

Founding Team

Volker Landschütze

Chief Technology Officer - CTO (fractional)

Executive Team

Ursula La Cognata

Chief Operating Officer COO fractional

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Grew 27% QoQ from 11 to 14 employees.

  • Jun 10, 2026

    Grew 38% QoQ, from 8 to 11 employees.

eversyn GmbH Filings

Explore SEC and related filing metadata, where available.

eversyn GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about eversyn GmbH's valuation, stock price, and market status.

Is eversyn GmbH a public or private company?

eversyn GmbH is a private company.

What is the current stock price of eversyn GmbH?

eversyn GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is eversyn GmbH worth (valuation)?

Valuation information for eversyn GmbH is not publicly available.

Can I buy eversyn GmbH stock?

eversyn GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was eversyn GmbH's last funding round?

eversyn GmbH's most recent funding round was Grant on June 1, 2026.

Who are the main investors in eversyn GmbH?

Key investors in eversyn GmbH include Bmp Ventures.

Will eversyn GmbH IPO soon?

No public IPO plans have been announced for eversyn GmbH.

How can I track eversyn GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor eversyn GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMagdeburg
Employee Range12
Year Founded2022
Last FundingJun 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?